CLINICAL_TRIALS
trial_result
· 2017-03-09
Clinical Trial Update: Sodium Stibogluconate Treatment of Leishmaniasis [Phase 2]
Summary
A Phase 2 clinical trial evaluating sodium stibogluconate for leishmaniasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: U.S. Army Medical Research and Development Command | Conditions: Leishmaniasis | Phase 2 | Status: COMPLETED | Results posted: 2017-03-09